Home
About
FAQ
History (33)
Principal Investigator
Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study.
Combination therapy with onasemnogene and risdiplam in spinal muscular atrophy type 1.
Does rural Mississippi have access to emergency neurosurgical care?
Visual Acuity Outcomes in Diabetic Macular Edema With Fluocinolone Acetonide 0.2 µg/Day Versus Ranibizumab Plus Deferred Laser (DRCR Protocol I).
See All 33 Pages
Find People
Find Everything
Edit My Profile
My Person List (
0
)
Return to Top
Login
Username
Password